Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-29

Clinical Trial Update: Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing catheter ablation to amiodarone for shock prevention in patients with defibrillators and ventricular tachycardia; study terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • catheter ablation

Snippet

Sponsor: Population Health Research Institute | Conditions: Defibrillators, Implantable, Tachycardia, Ventricular | Phase 3 | Status: TERMINATED | Results posted: 2020-01-29